Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
74 participants
INTERVENTIONAL
2022-03-16
2025-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CSC-SD
Standard clinic-based CSC model treatment. Treatment will be delivered largely in clinic for 12 months.
Coordinated Specialty Care (CSC)
CSC care is an evidenced-based, comprehensive specialty care programs for young people in the initial phases of psychotic disorders
CSC-TH
Telehealth based CSC model treatment. Treatment will be delivered largely through telehealth for 12 months.
Coordinated Specialty Care (CSC)
CSC care is an evidenced-based, comprehensive specialty care programs for young people in the initial phases of psychotic disorders
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coordinated Specialty Care (CSC)
CSC care is an evidenced-based, comprehensive specialty care programs for young people in the initial phases of psychotic disorders
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to give informed consent
3. Willing and able to adhere to the study schedule
4. New intakes enrolled in one of the six clinical programs
5. Non-affective (schizophrenia, schizoaffective, schizophreniform) and affective (major depression with psychotic features, bipolar disorder with psychotic features) psychotic disorders with onsets within 5 years of enrollment.
Exclusion Criteria
16 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Ohio State University
OTHER
Vanderbilt University
OTHER
Tulane University
OTHER
University of Rochester
OTHER
Yale University
OTHER
National Institute of Mental Health (NIMH)
NIH
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alan Breier
Raymond E. Houk Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan Breier
Role: PRINCIPAL_INVESTIGATOR
Indiana University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prevention and Recovery Center for Early Psychosis
Indianapolis, Indiana, United States
Early Psychosis Intervention Clinic-New Orleans (EPIC-NOLA) - Tulane University
New Orleans, Louisiana, United States
Program for Risk Evaluation and Prevention (PREP) - University of Michigan
Ann Arbor, Michigan, United States
Strong Ties Young Adults Program- University of Rochester Medical Center
Rochester, New York, United States
The Early Psychosis Intervention Center (EPICENTER) at Ohio State
Columbus, Ohio, United States
Vanderbilt's Early Psychosis Program - Vanderbilt University
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
epinet
Identifier Type: -
Identifier Source: org_study_id